Literature DB >> 32561592

Primary care reform and funding equity for mental health disorders in Ontario: a retrospective observational population-based study.

Imaan Bayoumi1, Susan E Schultz2, Richard H Glazier2.   

Abstract

BACKGROUND: Mental health disorders are associated with high morbidity and reduced life expectancy, and are largely managed in primary care. We sought to assess the equity of distribution of new alternative payment models and teams introduced under primary care reform in Ontario for patients with mental health disorders.
METHODS: We conducted a retrospective observational study using population-level administrative data for insured Ontario adults (age ≥ 18 yr) to identify all primary care payments to physicians that were allocated to individual patients in 2002/03 and 2011/12. We identified patients with mental health disorders using validated algorithms, and modelled the relations between per capita primary care costs and mental health disorders over time, stratified by type of mental health or substance use disorder and type of primary care payment. In an adjusted model, we adjusted for age, sex, rurality, neighbourhood income quintile, immigrant status, comorbidity and primary care model. For comparative purposes, we also examined the distribution of primary care payments for people with diabetes mellitus.
RESULTS: Total per capita primary care payments increased more slowly over the study period for patients with mental health disorders (62.0%) than for the general population (88.3%). Total payments for patients with substance use disorders increased by 142.7%, largely owing to urine drug testing in opioid substitution clinics. Adjusted total payments for those with versus without mental health disorders decreased by 10% between 2002/03 and 2011/12, driven by lower alternative payments. Similar decreases, also driven by lower alternative payments, were found for all mental health disorder subgroups except substance use and for diabetes.
INTERPRETATION: Payment and team reforms were associated with inequitable resource allocation to people with mental health disorders. The findings suggest the need for monitoring reforms for their impact on high-needs populations and making appropriate adjustments. Copyright 2020, Joule Inc. or its licensors.

Entities:  

Mesh:

Year:  2020        PMID: 32561592      PMCID: PMC7850171          DOI: 10.9778/cmajo.20190153

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  36 in total

1.  Access to primary care for homeless veterans with serious mental illness or substance abuse: a follow-up evaluation of co-located primary care and homeless social services.

Authors:  James McGuire; Lillian Gelberg; Jessica Blue-Howells; Robert A Rosenheck
Journal:  Adm Policy Ment Health       Date:  2009-03-12

Review 2.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos
Journal:  Lancet       Date:  2013-08-29       Impact factor: 79.321

Review 3.  Serious mental illness and the role of primary care.

Authors:  Claire Planner; Linda Gask; Siobhan Reilly
Journal:  Curr Psychiatry Rep       Date:  2014-08       Impact factor: 5.285

Review 4.  What is integrated care?

Authors:  Heather Huang; William Meller; Yasuhiro Kishi; Roger G Kathol
Journal:  Int Rev Psychiatry       Date:  2014-12

5.  Access to medical care among persons with psychotic and major affective disorders.

Authors:  Daniel W Bradford; Mimi M Kim; Loretta E Braxton; Christine E Marx; Marian Butterfield; Eric B Elbogen
Journal:  Psychiatr Serv       Date:  2008-08       Impact factor: 3.084

6.  Mental health care in the accountable care organization.

Authors:  Donovan T Maust; David W Oslin; Steven C Marcus
Journal:  Psychiatr Serv       Date:  2013-09-01       Impact factor: 3.084

7.  Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC.

Authors:  Duneesha De Alwis; Michael T Lynskey; Angela M Reiersen; Arpana Agrawal
Journal:  Addict Behav       Date:  2014-04-13       Impact factor: 3.913

8.  The burden of premature opioid-related mortality.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; Stephen Cornish; J Michael Paterson; David N Juurlink
Journal:  Addiction       Date:  2014-07-07       Impact factor: 6.526

9.  Closing the False Divide: Sustainable Approaches to Integrating Mental Health Services into Primary Care.

Authors:  Kurt Kroenke; Jurgen Unutzer
Journal:  J Gen Intern Med       Date:  2017-02-27       Impact factor: 5.128

10.  Primary care access for mental illness in Australia: Patterns of access to general practice from 2006 to 2016.

Authors:  Louise M Farrer; Jennie Walker; Christopher Harrison; Michelle Banfield
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

View more
  3 in total

1.  Implementing High-Quality Primary Care Through a Health Equity Lens.

Authors:  Azza Eissa; Robyn Rowe; Andrew Pinto; George N Okoli; Kendall M Campbell; Judy C Washington; José E Rodríguez
Journal:  Ann Fam Med       Date:  2022-02-14       Impact factor: 5.166

2.  Suicide and self-harm in adult survivors of critical illness: population based cohort study.

Authors:  Shannon M Fernando; Danial Qureshi; Manish M Sood; Michael Pugliese; Robert Talarico; Daniel T Myran; Margaret S Herridge; Dale M Needham; Bram Rochwerg; Deborah J Cook; Hannah Wunsch; Robert A Fowler; Damon C Scales; O Joseph Bienvenu; Kathryn M Rowan; Magdalena Kisilewicz; Laura H Thompson; Peter Tanuseputro; Kwadwo Kyeremanteng
Journal:  BMJ       Date:  2021-05-05

3.  Examining Access to Primary Care for People With Opioid Use Disorder in Ontario, Canada: A Randomized Clinical Trial.

Authors:  Sheryl Spithoff; Lana Mogic; Susan Hum; Rahim Moineddin; Christopher Meaney; Tara Kiran
Journal:  JAMA Netw Open       Date:  2022-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.